GC

Glenn D. Crater

TI Theravance Biopharma R&D Ip: 2 patents #14 of 70Top 20%
📍 Mississauga, CA: #54 of 412 inventorsTop 15%
Overall (2023): #154,577 of 537,848Top 30%
2
Patents 2023

Issued Patents 2023

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
11786517 Methods of treatment using a JAK inhibitor compound Melanie A. Kleinschek 2023-10-17
11667637 Fused imidazo-piperidine JAK inhibitors Paul R. Fatheree, Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden +1 more 2023-06-06